1. Market Research
  2. > Healthcare
  3. > Pathology
  4. > Mental Health Market Trends

Global Anxiety Disorders Market 2015-2019

  • January 2015
  • 73 pages
  • Infiniti Research Limited
Report ID: 2621943

Summary

Table of Contents

Search Inside

About Anxiety Disorders
Anxiety is associated with uneasiness, fearfulness, and tension. Mild anxiety, for example, associated with exams or interview, is normal and triggers 'fight or flight' response. Anxiety without an identifiable cause, anxiety which persists even after the stressful condition is over, and anxiety which is out of proportion of the stressful condition indicates abnormal anxiety. However, severe and persistent anxiety can interfere with everyday activities and might lead to other psychic problems. Anxiety disorder is a mental health disorder characterized by the presence of anxiety. These disorders might occur simultaneously with other disorders such as depression, or along with drug abuse.
TechNavio's analysts forecast the Global Anxiety Disorders market to grow at a CAGR of 4.02 percent over the period 2014-2019.

Covered in this Report
This report covers the present scenario and the growth prospects of the Global Anxiety Disorders market for the period 2015-2019. To calculate the market size, the report considers the revenue generated through the sales of drugs approved for the treatment of the following anxiety disorders:
• GAD
• Panic Disorder
• OCD
• PTSD
• Social Anxiety Disorder
• Special Phobias
• BDD
The report presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Anxiety Disorders market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.
TechNavio's report, Global Anxiety Disorders Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Anxiety Disorders market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
• Americas
• APAC
• EMEA

Key Vendors
• Eli Lilly and Company
• GlaxoSmithKline
• Pfizer
Other Prominent Vendors

• Abbott Laboratories
• Actavis
• Baxter International
• F. Hoffmann-La Roche
• Noven Pharmaceuticals
• Recordati Rare Diseases
• Shionogi
• Sumitomo Dainippon Pharma


Market Driver
• Increase in Patient Population
• For a full, detailed list, view our report

Market Challenge
• Poor Diagnoses Rates
• For a full, detailed list, view our report

Market Trend
• Increased Focus on Emerging Markets
• For a full, detailed list, view our report

Key Questions Answered in this Report
• What will the market size be in 2019 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

Veronica helps you find the right report:

Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

Purchase Reports From Reputable Market Research Publishers

Global Anxiety and Panic Disorders Drugs Market 2017-2021

  • $ 3500
  • Industry report
  • May 2017
  • by Infiniti Research Limited

About Anxiety and Panic Disorders Drugs Anxiety is a normal reaction to stress, which helps to deal with tense situations. However, when anxiety becomes an excessive and irrational extension of everyday ...

Agoraphobia Global Clinical Trials Review, H1, 2017

  • $ 2500
  • Industry report
  • March 2017
  • by GlobalData

Agoraphobia Global Clinical Trials Review, H1, 2017 Summary GlobalData’s clinical trial report, “Agoraphobia Global Clinical Trials Review, H1, 2017" provides an overview of Agoraphobia clinical trials ...

The 2018-2023 World Outlook for Anxiety Disorder Therapeutics

  • $ 995
  • Industry report
  • April 2017
  • by ICON Group

This study covers the world outlook for anxiety disorder therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.